Indacaterol, a novel inhaled beta2-agonist, provides sustained 24-h bronchodilation in asthma.
about
Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adultsIntermittent versus daily inhaled corticosteroids for persistent asthma in children and adultsOnset of action of indacaterol in patients with COPD: comparison with salbutamol and salmeterol-fluticasoneClinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β2-adrenoreceptor agonist (uLABA).Dose-finding evaluation of once-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with asthma: results of a parallel-group study and a crossover study.New approaches to managing asthma: a US perspectiveMometasone furoate dry-powder inhaler for the control of persistent asthma.Novel long-acting bronchodilators for COPD and asthmaThe long-acting beta-adrenoceptor agonist, indacaterol, inhibits IgE-dependent responses of human lung mast cells.Indacaterol, A Novel Once Daily Inhaled beta2-Adrenoreceptor Agonist.Mometasone furoate: an inhaled glucocorticoid for the management of asthma in adults and children.Indacaterol: a new once daily long-acting beta(2) adrenoceptor agonist.Indacaterol: pharmacologic profile, efficacy and safety in the treatment of adults with COPD.Long-acting β-adrenoceptor agonists in the management of COPD: focus on indacaterol.Indacaterol: a novel long-acting β(2) -agonist.Turning a molecule into a medicine: the development of indacaterol as a novel once-daily bronchodilator treatment for patients with COPD.Beta-Adrenergic AgonistsPharmacogenetic characterization of indacaterol, a novel beta 2-adrenoceptor agonist.Slow receptor dissociation is not a key factor in the duration of action of inhaled long-acting β2-adrenoceptor agonistsEfficacy and safety of indacaterol, a new 24-hour beta2-agonist, in patients with asthma: a dose-ranging study.
P2860
Q24200804-6AFF1937-B9DD-4B3C-A43E-950D379C24E9Q24202489-90989E8A-B772-4FB4-B64A-70204F4ED3B5Q34128947-C155DD8B-14D5-4A0B-9B0A-6065FD551EA6Q35088023-D1D7BC12-857A-4CF6-B1F0-992C5054ACBAQ35965128-B3DDF159-FD23-4FE9-95AC-67EF6D5C7765Q36823534-522626AA-3E5D-4A5B-B730-16E934B724A7Q36979360-F39F58A7-57A3-40E1-A24B-970619120C1EQ37208308-E2D570A9-8D2F-4904-B49A-406A4214F8DEQ37481301-60026D8B-09BA-4F1D-83B6-D179D836BFCEQ37487619-3A5E9B3D-C9BF-4F47-B739-FF614B469AADQ37556510-95685E09-275A-4DE7-93C1-DDBA34836C53Q37778736-09C898B3-972C-4415-8DD0-29AFD58303A1Q37846698-5C88E577-749F-4307-9073-6A8B8BC9E69EQ37911291-394D9F07-8806-428E-9248-B617A07115C4Q38002357-1BF99409-CEC4-4BA2-BF35-2FCD4BFA3415Q38248438-6B92594D-225E-46F7-9990-EDC939FBF589Q38974241-584E0DAA-2A37-401E-91E2-3E10B7E66635Q39855476-574C64CB-EC01-42CB-9169-4A5B33464A7AQ42283741-A8107100-CCEE-45BA-9C62-AA201461B31CQ46196657-2998A0A0-9416-4552-83A3-849EE7389A27
P2860
Indacaterol, a novel inhaled beta2-agonist, provides sustained 24-h bronchodilation in asthma.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Indacaterol, a novel inhaled b ...... 4-h bronchodilation in asthma.
@ast
Indacaterol, a novel inhaled b ...... 4-h bronchodilation in asthma.
@en
Indacaterol, a novel inhaled b ...... 4-h bronchodilation in asthma.
@nl
type
label
Indacaterol, a novel inhaled b ...... 4-h bronchodilation in asthma.
@ast
Indacaterol, a novel inhaled b ...... 4-h bronchodilation in asthma.
@en
Indacaterol, a novel inhaled b ...... 4-h bronchodilation in asthma.
@nl
prefLabel
Indacaterol, a novel inhaled b ...... 4-h bronchodilation in asthma.
@ast
Indacaterol, a novel inhaled b ...... 4-h bronchodilation in asthma.
@en
Indacaterol, a novel inhaled b ...... 4-h bronchodilation in asthma.
@nl
P2093
P1476
Indacaterol, a novel inhaled b ...... 4-h bronchodilation in asthma.
@en
P2093
P304
P356
10.1183/09031936.00060006
P577
2007-01-24T00:00:00Z